ImmuPharma PLC Tangible Net Worth Ratio
ImmuPharma PLC tangible net worth ratio. ImmuPharma PLC (IMM) has a Tangible Net Worth Ratio of 98.5% as of June 2025. This metric is calculated by deducting intangible assets (GBX5.00K) from net assets (GBX336.70K) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Check asset allocation strategy of ImmuPharma PLC to assess the company's strategic physical and investment asset allocation.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Tangible Net Worth Ratio of ImmuPharma PLC (2004–2023)
Tangible net worth ratio of ImmuPharma PLC from 2004 to 2023. This chart shows how ImmuPharma PLC's Tangible Net Worth Ratio has changed across 21 annual periods from 2004 to 2023. As of June 2025, the ratio stands at 98.5%, reflecting net assets of GBX336.70K with intangible assets of GBX5.00K GBX. See ImmuPharma PLC working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
ImmuPharma PLC Tangible Net Worth Ratio by Year (2004–2023)
ImmuPharma PLC tangible net worth ratio by year from 2004 to 2023. The table below presents the year-by-year Tangible Net Worth Ratio for ImmuPharma PLC from 2004 to 2023, covering 21 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For live market cap and overall valuation, see market value of ImmuPharma PLC.
| Year | Tangible NW Ratio | Net Assets (GBX) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2023 | 57.6% | GBX1.06 Million | GBX447.57K | GBX2.72 Million | ▼ -23.6 pp |
| 2022 | 81.2% | GBX2.52 Million | GBX473.89K | GBX3.97 Million | ▼ -8.0 pp |
| 2021 | 89.2% | GBX4.41 Million | GBX477.55K | GBX6.00 Million | ▼ -5.8 pp |
| 2020 | 95.0% | GBX9.65 Million | GBX484.04K | GBX10.92 Million | ▲ +4.1 pp |
| 2019 | 90.9% | GBX5.27 Million | GBX478.96K | GBX5.80 Million | ▼ -2.8 pp |
| 2018 | 93.7% | GBX7.62 Million | GBX483.04K | GBX8.66 Million | ▲ +7.2 pp |
| 2017 | 86.5% | GBX3.57 Million | GBX482.27K | GBX5.02 Million | ▼ -4.3 pp |
| 2016 | 90.8% | GBX5.55 Million | GBX511.09K | GBX6.71 Million | ▲ +21.7 pp |
| 2015 | 69.1% | GBX1.69 Million | GBX522.46K | GBX3.21 Million | ▼ -21.1 pp |
| 2014 | 90.2% | GBX5.71 Million | GBX560.54K | GBX7.07 Million | ▲ +1.3 pp |
| 2013 | 88.9% | GBX5.40 Million | GBX602.07K | GBX7.21 Million | ▼ -3.7 pp |
| 2012 | 92.5% | GBX8.42 Million | GBX627.68K | GBX10.51 Million | ▼ -2.1 pp |
| 2011 | 94.7% | GBX12.51 Million | GBX666.00K | GBX14.28 Million | ▼ -0.9 pp |
| 2010 | 95.6% | GBX15.97 Million | GBX705.00K | GBX17.55 Million | ▼ -0.3 pp |
| 2009 | 95.9% | GBX18.08 Million | GBX747.00K | GBX24.64 Million | ▲ +3.1 pp |
| 2008 | 92.8% | GBX11.24 Million | GBX809.00K | GBX13.40 Million | ▲ +17.6 pp |
| 2007 | 75.2% | GBX3.05 Million | GBX755.00K | GBX4.10 Million | ▼ -12.0 pp |
| 2006 | 87.3% | GBX5.89 Million | GBX749.00K | GBX7.33 Million | ▲ +17.8 pp |
| 2006 | 69.4% | GBX2.50 Million | GBX765.00K | GBX3.63 Million | ▼ -30.6 pp |
| 2005 | 100.0% | GBX993.00K | GBX0.00 | GBX1.01 Million | ▲ +0.0 pp |
| 2004 | 100.0% | GBX978.00K | GBX0.00 | GBX980.00K | — |